Portfolio Holdings Detail for ISIN IE00BFNM3J75
| Stock Name / Fund | iShares MSCI World ESG Screened UCITS ETF |
| Issuer | Blackrock |
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67
| ETF Ticker | SNAW(EUR) F |
| ETF Ticker | SAWD.LS(USD) CXE |
| ETF Ticker | SAWD.MI(EUR) CXE |
| ETF Ticker | SAWDx(GBP) CXE |
| ETF Ticker | SAWDz(USD) CXE |
| ETF Ticker | SNAW.DE(EUR) CXE |
| ETF Ticker | SAWD(EUR) ETF Plus |
Holdings detail for VRTX
| Stock Name | Vertex Pharmaceuticals Inc |
| Ticker | VRTX(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US92532F1003 |
| LEI | 54930015RAQRRZ5ZGJ91 |
Show aggregate VRTX holdings
News associated with VRTX
- Vertex Pharmaceuticals Secures Italian Reimbursement Agreement For Gene-Edited Therapy CASGEVY
- (RTTNews) - Vertex Pharmaceuticals (VRTX), Thursday announced a reimbursement agreement with the Italian Medicines Agency that allows eligible transfusion-dependent beta thalassemia and severe sickle cell disease patients to access the CRISPR/Cas9 gene-edited therapy CASGEVY. - 2025-09-18 14:26:15
- Why This Biotech Company Could Be a Growth Stock Powerhouse
- Key PointsThis biotech is a leader in the treatment of cystic fibrosis, and that’s helped earnings explode higher over the years. - 2025-09-17 06:10:00
- 3 Absurdly Cheap Stocks to Buy for the Long Haul
- Key PointsThese stocks are all down for the year, and things could get worse before they get better. - 2025-09-12 08:30:00
- My 2 Favorite Stocks to Buy Right Now
- Key PointsAmazon has multiple moats and paths to grow. - 2025-08-31 05:51:00
- Capital Group Growth ETF Experiences Big Inflow
- Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Capital Group Growth ETF (Symbol: CGGR) where we have detected an approximate $162.3 million dollar inflow -- that's a 1.1% increase week over week i - 2025-08-29 11:52:16
- Noteworthy ETF Inflows: CGBL, CGCP, CGCB, VRTX
- Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Capital Group Core Balanced ETF (Symbol: CGBL) where we have detected an approximate $272.2 million dollar inflow -- that's a 9.7% increase week over - 2025-08-15 11:50:39
- 2 Growth Stocks That Are No-Brainer Buys Right Now
- Key PointsVertex Pharmaceuticals' recent dip presents an excellent buying opportunity, given its promising prospects. - 2025-08-15 09:30:00
- Vertex Pharmaceuticals (NASDAQ:VRTX) Rating Increased to Strong-Buy at Wall Street Zen
- Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) was upgraded by investment analysts at Wall Street Zen from a “hold” rating to a “strong-buy” rating in a report issued on Saturday. A number of other research firms have also recently weighed in on VRTX. Wells Fargo & Company raised shares of Vertex Pharmaceuticals from an “equal […] - 2025-08-11 02:58:48
- The Smartest Growth Stocks to Buy With $1,000 Right Now
- Key PointsVertex Pharmaceuticals' recent sell-off was overdone. - 2025-08-09 05:46:00
- 5 Top Stocks to Buy in August
- Key PointsThe pullback in Netflix, Costco, and ASML is a buying opportunity. - 2025-08-08 07:45:00
- Harbour Investments Inc. Acquires 68 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
- Harbour Investments Inc. increased its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 19.9% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 410 shares of the pharmaceutical company’s stock after purchasing an additional 68 shares during the period. Harbour […] - 2025-08-07 05:54:57
- Vertex Pharmaceuticals (NASDAQ:VRTX) Reaches New 52-Week Low on Analyst Downgrade
- Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Free Report)’s share price hit a new 52-week low during trading on Wednesday after Canaccord Genuity Group lowered their price target on the stock from $424.00 to $411.00. Canaccord Genuity Group currently has a hold rating on the stock. Vertex Pharmaceuticals traded as low as $373.19 and last traded […] - 2025-08-07 05:08:45
- Scotiabank Issues Pessimistic Forecast for Vertex Pharmaceuticals (NASDAQ:VRTX) Stock Price
- Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its price target lowered by Scotiabank from $442.00 to $438.00 in a report released on Tuesday,Benzinga reports. The firm presently has a “sector perform” rating on the pharmaceutical company’s stock. Scotiabank’s target price suggests a potential upside of 13.57% from the company’s current price. Other research analysts […] - 2025-08-07 03:14:58
- Vertex Pharmaceuticals (NASDAQ:VRTX) PT Set at $490.00 by Truist Financial
- Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) received a $490.00 price objective from Truist Financial in a report issued on Tuesday, MarketBeat reports. The firm presently has a “buy” rating on the pharmaceutical company’s stock. Truist Financial’s price objective indicates a potential upside of 27.06% from the company’s previous close. A number of other equities […] - 2025-08-07 03:14:58
- Vertex Pharmaceuticals (NASDAQ:VRTX) Shares Gap Down Following Analyst Downgrade
- Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Free Report) shares gapped down before the market opened on Tuesday after Canaccord Genuity Group lowered their price target on the stock from $424.00 to $411.00. The stock had previously closed at $472.27, but opened at $408.22. Canaccord Genuity Group currently has a hold rating on the stock. Vertex […] - 2025-08-07 02:42:43
- Stocks Settle Lower as US Service Sector Activity Weakens
- The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 14:19:48
- Wednesday's ETF with Unusual Volume: LSGR
- The Natixis Loomis Sayles Focused Growth ETF is seeing unusually high volume in afternoon trading Wednesday, with over 805,000 shares traded versus three month average volume of about 45,000. Shares of LSGR were up about 0.4% on the day.
Components of that ETF with the highest - 2025-08-06 13:11:25
- Stocks Settle Lower as US Service Sector Activity Weakens
- The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 12:43:55
- Stocks Settle Lower as US Service Sector Activity Weakens
- The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 12:20:27
- Stocks Settle Lower as US Service Sector Activity Weakens
- The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 10:31:46
- Stocks Settle Lower as US Service Sector Activity Weakens
- The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 10:01:41
- Stocks Settle Lower as US Service Sector Activity Weakens
- The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 08:50:42
- Stocks Settle Lower as US Service Sector Activity Weakens
- The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 08:02:58
- Stocks Settle Lower as US Service Sector Activity Weakens
- The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 05:54:32
- Royal Bank Of Canada Lowers Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target to $405.00
- Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its price objective trimmed by Royal Bank Of Canada from $430.00 to $405.00 in a research report sent to investors on Tuesday morning,Benzinga reports. The brokerage currently has a sector perform rating on the pharmaceutical company’s stock. A number of other equities research analysts have also issued reports […] - 2025-08-06 04:40:55
- Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Cut to $455.00 by Analysts at Stifel Nicolaus
- Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its price objective reduced by Stifel Nicolaus from $494.00 to $455.00 in a research note issued to investors on Tuesday morning,Benzinga reports. Stifel Nicolaus currently has a hold rating on the pharmaceutical company’s stock. VRTX has been the topic of several other reports. Scotiabank dropped their target price […] - 2025-08-06 04:40:55
- HC Wainwright Has Lowered Expectations for Vertex Pharmaceuticals (NASDAQ:VRTX) Stock Price
- Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its target price decreased by HC Wainwright from $550.00 to $478.00 in a research report released on Tuesday,Benzinga reports. HC Wainwright currently has a buy rating on the pharmaceutical company’s stock. A number of other equities research analysts have also recently weighed in on VRTX. Leerink Partnrs cut […] - 2025-08-06 04:40:51
- Stocks Settle Lower as US Service Sector Activity Weakens
- The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 04:21:54
- Stocks Settle Lower as US Service Sector Activity Weakens
- The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 02:12:19
- Stocks Pressured by Disappointing US Service Sector News
- The S&P 500 Index ($SPX ) (SPY ) today is down -0.57%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.51%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.62%. September E-mini S&P futures (ESU25 ) are down -0.55%, and September E-mini Nasdaq futures... - 2025-08-05 19:47:15
iShares MSCI World ESG Screened UCITS ETF VRTX holdings
| Date | Number of VRTX Shares Held | Base Market Value of VRTX Shares | Local Market Value of VRTX Shares | Change in VRTX Shares Held | Change in VRTX Base Value | Current Price per VRTX Share Held | Previous Price per VRTX Share Held |
|---|
| 2025-11-28 (Friday) | 20,527 | USD 8,900,712 | USD 8,900,712 | | | | |
| 2025-11-27 (Thursday) | 20,322 | USD 8,782,559 | USD 8,782,559 | 0 | USD 0 | USD 432.17 | USD 432.17 |
| 2025-11-26 (Wednesday) | 20,322 | USD 8,782,559 | USD 8,782,559 | 0 | USD 47,757 | USD 432.17 | USD 429.82 |
| 2025-11-25 (Tuesday) | 20,322 | USD 8,734,802 | USD 8,734,802 | 82 | USD 153,042 | USD 429.82 | USD 424 |
| 2025-11-24 (Monday) | 20,240 | USD 8,581,760 | USD 8,581,760 | 0 | USD -55,862 | USD 424 | USD 426.76 |
| 2025-11-21 (Friday) | 20,240 | USD 8,637,622 | USD 8,637,622 | 42 | USD 107,603 | USD 426.76 | USD 422.32 |
| 2025-11-20 (Thursday) | 20,198 | USD 8,530,019 | USD 8,530,019 | 0 | USD 26,055 | USD 422.32 | USD 421.03 |
| 2025-11-19 (Wednesday) | 20,198 | USD 8,503,964 | USD 8,503,964 | 0 | USD -292,669 | USD 421.03 | USD 435.52 |
| 2025-11-18 (Tuesday) | 20,198 | USD 8,796,633 | USD 8,796,633 | 0 | USD 30,297 | USD 435.52 | USD 434.02 |
| 2025-11-17 (Monday) | 20,198 | USD 8,766,336 | USD 8,766,336 | 0 | USD -10,099 | USD 434.02 | USD 434.52 |
| 2025-11-13 (Thursday) | 20,198 | USD 8,776,435 | USD 8,776,435 | 0 | USD 107,049 | USD 434.52 | USD 429.22 |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of VRTX by Blackrock for IE00BFNM3J75
Show aggregate share trades of VRTX| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-11-25 | BUY | 82 | | | 429.820* | | 457.78 |
| 2025-11-21 | BUY | 42 | | | 426.760* | | 458.07 |
| 2025-10-30 | BUY | 533 | 422.950 | 415.000 | 415.795 | USD 221,619 | 460.19 |
| 2025-10-27 | BUY | 123 | 420.170 | 423.610 | 423.266 | USD 52,062 | 460.57 |
| 2025-10-22 | BUY | 82 | 426.440 | 431.810 | 431.273 | USD 35,364 | 461.11 |
| 2025-10-16 | BUY | 82 | 408.610 | 413.310 | 412.840 | USD 33,853 | 461.98 |
| 2025-09-18 | SELL | -111 | 387.110 | 390.660 | 390.305 | USD -43,324 | 465.52 Profit of 8,349 on sale |
| 2025-09-17 | BUY | 123 | 387.150 | 396.310 | 395.394 | USD 48,633 | 465.93 |
| 2025-08-21 | SELL | -328 | 397.460 | 399.000 | 398.846 | USD -130,821 | 467.91 Profit of 22,654 on sale |
| 2025-07-16 | SELL | -41 | 469.550 | 470.940 | 470.801 | USD -19,303 | 470.44 Loss of -15 on sale |
| 2025-07-15 | BUY | 41 | 464.200 | 475.290 | 474.181 | USD 19,441 | 470.47 |
| 2025-07-08 | SELL | -82 | 466.360 | 470.340 | 469.942 | USD -38,535 | 470.39 Profit of 37 on sale |
| 2025-06-17 | BUY | 115 | 441.990 | 452.710 | 451.638 | USD 51,938 | 472.38 |
| 2025-06-09 | BUY | 41 | 446.150 | 451.520 | 450.983 | USD 18,490 | 473.19 |
| 2025-05-29 | SELL | -80 | 447.090 | 449.220 | 449.007 | USD -35,921 | 474.58 Profit of 2,046 on sale |
| 2025-05-20 | BUY | 80 | 447.180 | 448.000 | 447.918 | USD 35,833 | 476.43 |
| 2025-05-16 | BUY | 164 | 438.650 | 438.950 | 438.920 | USD 71,983 | 477.00 |
| 2025-05-14 | BUY | 156 | 421.160 | 433.410 | 432.185 | USD 67,421 | 477.77 |
| 2025-05-13 | SELL | -240 | 432.000 | 442.120 | 441.108 | USD -105,866 | 478.14 Profit of 8,887 on sale |
| 2025-05-08 | SELL | -80 | 429.600 | 432.140 | 431.886 | USD -34,551 | 479.28 Profit of 3,792 on sale |
| 2025-04-25 | SELL | -40 | 493.840 | 494.920 | 494.812 | USD -19,792 | 478.62 Loss of -648 on sale |
| 2025-04-15 | BUY | 360 | 500.490 | 501.910 | 501.768 | USD 180,636 | 477.79 |
| 2025-04-11 | SELL | -200 | 484.220 | 486.970 | 486.695 | USD -97,339 | 477.55 Loss of -1,828 on sale |
| 2025-04-10 | BUY | 80 | 475.490 | 480.000 | 479.549 | USD 38,364 | 477.57 |
| 2025-04-09 | BUY | 120 | 482.300 | 487.150 | 486.665 | USD 58,400 | 477.53 |
| 2025-04-08 | SELL | -185 | 472.370 | 483.940 | 482.783 | USD -89,315 | 477.58 Loss of -963 on sale |
| 2025-04-07 | SELL | -111 | 474.560 | 481.740 | 481.022 | USD -53,393 | 477.61 Loss of -379 on sale |
| 2025-03-28 | SELL | -120 | 492.690 | 504.790 | 503.580 | USD -60,430 | 477.27 Loss of -3,157 on sale |
| 2025-03-27 | BUY | 31 | 502.550 | 506.540 | 506.141 | USD 15,690 | 477.00 |
| 2025-03-13 | BUY | 40 | 502.920 | 512.750 | 511.767 | USD 20,471 | 473.30 |
| 2025-03-05 | SELL | -80 | 491.640 | 495.540 | 495.150 | USD -39,612 | 472.07 Loss of -1,846 on sale |
| 2025-02-26 | BUY | 123 | 479.100 | 484.980 | 484.392 | USD 59,580 | 471.50 |
| 2025-02-19 | BUY | 160 | 471.760 | 472.120 | 472.084 | USD 75,533 | 470.90 |
| 2025-02-14 | BUY | 240 | 459.000 | 469.550 | 468.495 | USD 112,439 | 471.40 |
| 2025-02-13 | BUY | 119 | 462.580 | 465.680 | 465.370 | USD 55,379 | 471.53 |
| 2025-02-12 | BUY | 82 | 453.200 | 455.660 | 455.414 | USD 37,344 | 471.82 |
| 2025-02-10 | BUY | 205 | 469.970 | 471.940 | 471.743 | USD 96,707 | 472.12 |
| 2025-02-07 | BUY | 82 | 469.320 | 480.470 | 479.355 | USD 39,307 | 472.16 |
| 2025-02-05 | BUY | 41 | 488.440 | 491.810 | 491.473 | USD 20,150 | 471.73 |
| 2025-02-04 | BUY | 74 | 482.280 | 482.740 | 482.694 | USD 35,719 | 471.55 |
| 2025-01-23 | BUY | 41 | 439.730 | 442.890 | 442.574 | USD 18,146 | 475.48 |
| 2024-12-10 | BUY | 123 | 469.220 | 476.460 | 475.736 | USD 58,516 | 475.61 |
| 2024-12-09 | BUY | 41 | 473.980 | 476.020 | 475.816 | USD 19,508 | 475.64 |
| 2024-12-04 | BUY | 41 | 463.980 | 464.870 | 464.781 | USD 19,056 | 476.55 |
| 2024-11-26 | BUY | 41 | 467.070 | 467.960 | 467.871 | USD 19,183 | 478.71 |
| 2024-11-26 | BUY | 41 | 467.070 | 467.960 | 467.871 | USD 19,183 | 478.71 |
| 2024-11-21 | BUY | 74 | 450.370 | 455.430 | 454.924 | USD 33,664 | 481.36 |
| 2024-11-20 | BUY | 82 | 451.230 | 451.760 | 451.707 | USD 37,040 | 482.27 |
| 2024-11-19 | BUY | 246 | 448.010 | 463.900 | 462.311 | USD 113,729 | 483.34 |
| 2024-11-18 | BUY | 312 | 467.010 | 468.880 | 468.693 | USD 146,232 | 483.87 |
| 2024-11-11 | BUY | 164 | 501.720 | 518.350 | 516.687 | USD 84,737 | 482.37 |
| 2024-11-11 | BUY | 164 | 501.720 | 518.350 | 516.687 | USD 84,737 | 482.37 |
| 2024-11-06 | BUY | 123 | 493.640 | 506.650 | 505.349 | USD 62,158 | 476.40 |
| 2024-11-06 | BUY | 123 | 493.640 | 506.650 | 505.349 | USD 62,158 | 476.40 |
| 2024-10-29 | BUY | 41 | 470.360 | 478.060 | 477.290 | USD 19,569 | 475.03 |
| 2024-10-29 | BUY | 41 | 470.360 | 478.060 | 477.290 | USD 19,569 | 475.03 |
| 2024-10-28 | BUY | 41 | 476.370 | 478.320 | 478.125 | USD 19,603 | 474.70 |
| 2024-10-28 | BUY | 41 | 476.370 | 478.320 | 478.125 | USD 19,603 | 474.70 |
| 2024-10-22 | BUY | 287 | 474.910 | 482.870 | 482.074 | USD 138,355 | 478.09 |
| 2024-10-22 | BUY | 287 | 474.910 | 482.870 | 482.074 | USD 138,355 | 478.09 |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of VRTX
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-09-19 | 253,408 | 88 | 822,586 | 30.8% |
| 2025-09-18 | 262,277 | 45 | 831,580 | 31.5% |
| 2025-09-17 | 158,866 | 890 | 1,012,591 | 15.7% |
| 2025-09-16 | 233,484 | 702 | 769,823 | 30.3% |
| 2025-09-15 | 385,606 | 97 | 605,410 | 63.7% |
| 2025-09-12 | 198,306 | 54 | 325,925 | 60.8% |
| 2025-09-11 | 217,651 | 160 | 455,823 | 47.7% |
| 2025-09-10 | 441,550 | 65 | 640,409 | 68.9% |
| 2025-09-09 | 216,563 | 711 | 395,377 | 54.8% |
| 2025-09-08 | 285,371 | 226 | 594,102 | 48.0% |
| 2025-09-05 | 209,916 | 9 | 413,663 | 50.7% |
| 2025-09-04 | 236,777 | 2,164 | 365,713 | 64.7% |
| 2025-09-03 | 212,085 | 7 | 457,751 | 46.3% |
| 2025-09-02 | 318,587 | 425 | 689,371 | 46.2% |
| 2025-08-29 | 136,055 | 7 | 344,317 | 39.5% |
| 2025-08-28 | 189,040 | 229 | 437,536 | 43.2% |
| 2025-08-27 | 204,685 | 373 | 919,772 | 22.3% |
| 2025-08-26 | 195,209 | 380 | 616,641 | 31.7% |
| 2025-08-25 | 205,216 | 929 | 405,536 | 50.6% |
| 2025-08-22 | 187,538 | 366 | 477,729 | 39.3% |
| 2025-08-21 | 357,256 | 454 | 694,264 | 51.5% |
| 2025-08-20 | 304,195 | 196 | 620,591 | 49.0% |
| 2025-08-19 | 193,253 | 370 | 598,168 | 32.3% |
| 2025-08-18 | 197,043 | 357 | 581,908 | 33.9% |
| 2025-08-15 | 213,454 | 413 | 509,240 | 41.9% |
| 2025-08-14 | 299,335 | 536 | 798,768 | 37.5% |
| 2025-08-13 | 342,897 | 6,746 | 694,047 | 49.4% |
| 2025-08-12 | 361,071 | 536 | 689,425 | 52.4% |
| 2025-08-11 | 478,787 | 177 | 1,141,772 | 41.9% |
| 2025-08-08 | 382,688 | 480 | 1,467,480 | 26.1% |
| 2025-08-07 | 802,775 | 500 | 1,747,924 | 45.9% |
| 2025-08-06 | 1,070,384 | 29,978 | 2,256,489 | 47.4% |
| 2025-08-05 | 2,087,742 | 66,027 | 4,981,303 | 41.9% |
| 2025-08-04 | 329,631 | 253 | 766,131 | 43.0% |
| 2025-08-01 | 290,545 | 239 | 729,079 | 39.9% |
| 2025-07-31 | 227,826 | 151 | 513,336 | 44.4% |
| 2025-07-30 | 134,793 | 234 | 361,144 | 37.3% |
| 2025-07-29 | 124,474 | 331 | 372,446 | 33.4% |
| 2025-07-28 | 125,989 | 264 | 519,868 | 24.2% |
| 2025-07-25 | 136,582 | 104 | 432,897 | 31.6% |
| 2025-07-24 | 144,869 | 169 | 321,736 | 45.0% |
| 2025-07-23 | 182,307 | 1,460 | 370,788 | 49.2% |
| 2025-07-22 | 193,759 | 402 | 450,155 | 43.0% |
| 2025-07-21 | 174,382 | 14,621 | 318,671 | 54.7% |
| 2025-07-18 | 203,357 | 10,091 | 296,802 | 68.5% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Note: All information is provided as is without warranty and should be used for indicative purposes only.
You should independently check data before making any investment decision.
This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.